TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EVE Health Group Limited ( (AU:EVE) ) has issued an update.
EVE Health Group Limited has announced that its next Annual General Meeting (AGM) will be held on or about November 6, 2025, with the re-election of directors as a key agenda item. The deadline for director nominations is set for September 18, 2025. This announcement is crucial for stakeholders as it outlines the timeline for potential changes in the company’s leadership, which could impact its strategic direction and operations.
More about EVE Health Group Limited
EVE Health Group (ASX: EVE) is an Australian-based health company focused on developing and commercializing evidence-based wellness and pharmaceutical products. Through its subsidiaries Meluka Australia and Nextract, EVE delivers science-led innovations to support consumer and practitioner health across retail, pharmacy, and clinical channels.
Average Trading Volume: 403,788
Technical Sentiment Signal: Sell
Current Market Cap: A$7.14M
For detailed information about EVE stock, go to TipRanks’ Stock Analysis page.